Dendritic Cell Cross-Priming Is Essential for Immune Responses to Listeria monocytogenes by Reinicke, Anna T. et al.
Dendritic Cell Cross-Priming Is Essential for Immune
Responses to Listeria monocytogenes
Anna T. Reinicke, Kyla D. Omilusik, Genc Basha, Wilfred A. Jefferies*
The Biomedical Research Centre, Michael Smith Laboratories, Departments of Medical Genetics, Microbiology and Immunology, and Zoology, The University of British
Columbia, Vancouver, British Columbia, Canada
Abstract
Cross-presentation is now recognized as a major mechanism for initiating CD8 T cell responses to virus and tumor antigens
in vivo. It provides an elegant mechanism that allows relatively few Dendritic cells (DCs) to initiate primary immune
responses while avoiding the consumptive nature of pathogenic infection. CD8 T cells play a major role in anti-bacterial
immune responses; however, the contribution of cross-presentation for priming CD8 T cell responses to bacteria, in vivo,i s
not well established. Listeria monocytogenes (Listeria) is the causative agent of Listeriosis, an opportunistic food-borne
bacterial infection that poses a significant public health risk. Here, we employ a transgenic mouse model in which cross-
presentation is uniquely inactivated, to investigate cross-priming during primary Listeria infection. We show that cross-
priming deficient mice are severely compromised in their ability to generate antigen-specific T cells to stimulate MHC I-
restricted CTL responses following Listeria infection. The defect in generation of Listeria-elicited CD8 T cell responses is also
apparent in vitro. However, in this setting, the endogenous route of processing Listeria-derived antigens is predominant.
This reveals a new experimental dichotomy whereby functional sampling of Listeria-derived antigens in vivo but not in vitro
is dependent on cross-presentation of exogenously derived antigen. Thus, under normal physiological circumstances, cross-
presentation is demonstrated to play an essential role in priming CD8 T cell responses to bacteria.
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Introduction
Antigen processing and subsequent presentation to specific T
cells is necessary for effective bacterial immune responses involving
both CD4 and CD8 T cells. While CD4 helper T cell responses
are necessary for limiting infection, CD8 cytotoxic T lymphocytes
are required for clearance of bacteria [1]. MHC class-II antigen
presentation is mainly restricted to internalized proteins that are
processed and loaded in phagosomal/endosomal compartments
for activation of CD4 T helper cells [2]. MHC I presentation is
classically restricted to endogenously synthesized antigens of viral
or self origin [3]. Such proteins are digested by the proteasome
and translocated into the endoplasmic reticulum (ER) via the
transporters associated with antigen processing, TAP1 and TAP2
for loading on MHC I. A second, less well-defined mechanism of
processing has also been described and is referred to as cross-
presentation whereby exogenously-derived antigens may be
captured from other sources and following uptake are processed
in such a way to access MHC I molecules for loading and
presentation [4].
There are several mechanisms proposed to explain how
exogenously-derived antigens that have been phagocytosed or
macropinocytosed may be processed and loaded on MHC I
molecules for presentation. In one model, exogenous antigens are
proposed to be processed directly in a compartment within the
endocytic pathway in a TAP and proteosome independent manner
where they are degraded by proteases and cathepsins for loading
[5–7]. In a second model, internalized antigens may be delivered
to the cytosol where they can follow the classical proteosome-
mediated degradation and entry to the ER via TAP for loading on
nascent MHC I molecules [8,9]. Membrane of the ER has been
proposed to fuse with the phagosome during phagocytosis [10]
that would allow the delivery of antigens into the cytosol. In
addition, ER phagosome fusion has also led to studies showing that
phagosomes are competent organelles for proteosome and TAP
dependent cross-presentation [11–13]. Thus, the mechanisms
proposed are non-mutually exclusive and the importance of one or
other may depend on the source of antigen.
Many antigens have been shown to be cross presented in vitro
including soluble proteins, cellular antigens, immune complexes,
intracellular bacteria and parasites [14]. Indeed, the primary
significance of cross-presentation is shown in vivo as a major
mechanism for initiating CD8 T cell priming [5,15]. A key role of
cross-priming in vivo has been demonstrated to initiate CTL
immunity during virus infection in a system where only non-
hematopoetic cells were infected and bone marrow-derived APCs
were shown to be required to capture viral antigens from infected
cells by cross-priming [16].
Cross-presentation of bacterial antigens on MHC I has been
demonstrated in vitro [17] and several groups have provided data
for a mechanism whereby apoptosis of infected cells would provide
the source of antigen and result in uptake of bacteria-encoded
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naı ¨ve T cell responses [18–20]. In vivo, pathogen-infected APCs
may be functionally compromised and DCs may not be directly
infected. Thus, we pose that an exogenous pathway for processing
bacterial-derived antigens to prime CD8 T cell responses would
indeed be required; however, this has not been directly addressed.
The contribution of cross-priming versus direct priming in
immunity to such intracellular pathogens in vivo is therefore not
well established owing to difficulties associated with distinguishing
these mechanisms of initiating cellular immune responses.
Recent data from our laboratory demonstrated that MHC I
trafficking is controlled by a highly conserved tyrosine located in
the cytoplasmic tail of the class I molecule. Transgenic mice
expressing either the wild type H-2K
b MHC I allele (K
bWT), or
H-2K
b containing a single point mutation substituting a
phenylalanine residue for the conserved tyrosine in exon 6 of
the molecule (DY) were generated and bred onto a H-2
K
background by backcrossing transgenic founders with C3H/He
mice. Our results showed that the highly conserved MHC I
cytoplasmic tyrosine residue forms part of an intracellular
targeting motif that is required for routing of MHC I molecules
through endolysosomal compartments in DCs where MHC I
loading of cross-presented exogenous peptides occurs [5]. The
functional consequences of the cytoplasmic tail mutation were
demonstrated for two anti-viral CTL responses in vivo whereby the
tyrosine mutation abrogated cross-priming of those viral epitopes.
Here, we are using this transgenic model system to address the
contribution of cross-priming during intracellular bacterial
infection.
Listeria monocytogenes (Listeria) is a gram-positive facultative
intracellular bacterial pathogen. It is the causative agent of
listeriosis, a food borne disease characterized by systemic infection
of Listeria disseminating from the intestine into the blood stream
and organs. Listeriosis is the leading cause of death among
pathogenic bacteria. Pregnant women, neonates, and elderly or
immunocompromised individuals are particularly at risk from
infection but apparently healthy individuals may also be affected.
Listeriosis is normally sporadic with few cases per year but
outbreaks of epidemic proportions still occur. Following entry into
the host cell Listeria expresses a virulence factor, Listeriolysin O
(LLO). This lyses the phagosomal membrane and allows the
bacteria to escape the phagosome into the cytosol where it survives
and replicates. Listeria infection can spread from cell to cell without
entering the extracellular domain and therefore a functional CD8
T cell response is required for clearance of the bacteria and
development of protective immunity [21–23]. Listeria-derived
MHC I- restricted peptides may be generated from proteins
secreted into the cytosol such as the virulence determinant, LLO
[24]. Thus, secreted bacterial proteins may be directed through
the classical endogenous route of processing for presentation on
MHC I. However, following infection in vivo, bacteria are found
preferentially within the cytosol of macrophages and hepatocytes
in the spleen and liver [25]. Therefore, professional antigen
presenting cells (pAPCs) such as DCs may internalize antigens
from infected cells or bacterially-derived apoptotic debris for
initiation of CD8 T cell responses.
DCs are now considered essential for priming of naı ¨ve CD8 T
cell responses owing to their unique maturation and migration
ability, high expression of co-stimulatory molecules, and unique
pH sensing and NADPH oxidase 2 (NOX2) activity [26]. Indeed,
DCs are extraordinarily well adapted to cross present antigens to
CD8 T cells most efficiently [5,27]. Further, DCs have been
shown to be essential in immune responses to bacterial pathogens
since they are critical in priming CD8 T cells to bacterial
pathogens. In one study, a diphtheria toxin-based system was used
to induce short-term ablation of DCs and showed that the anti-
Listeria CTL response was critically dependent on DCs [28]. In a
second study, Lenz et al. showed that the priming of CTL to
Listeria is restricted to bm-derived APCs [29]. Thus, DC cross-
priming of CD8 T cells may provide an important means of
alerting cellular immune responses to Listeria monocytogenes bacterial
infection. Here, we directly examine the hypothesis that cross-
presentation is essential for initiating CD8 T cell responses and
mount anti-bacterial responses in vivo.
Results
The strength of an antigen specific CD8 T cell response
following Listeria-OVA infection in vivo differs depending
on the route of infection
Following Listeria infection, bacteria are preferentially found
within the cytosol of macrophages and hepatocytes of the spleen
and liver [25]. Bacteria spread from cell to cell without leaving the
intracellular compartment, thereby making CD8 T cell activation
crucial for clearance of the bacteria and induction of protective
immunity [30]. The route of administration of bacteria may
greatly affect the strength and type of adaptive immune response
generated. In particular, the contribution of cross-presentation
may be influenced. Here, we examined primary CD8 T cell
responses following i.v. and oral gavage infection of C57BL/6
mice to establish a model examining the initiation of adaptive
immunity to Listeria. In order to analyse Ag-specific CD8 T cell
responses to Listeria infection, a recombinant Listeria strain (Listeria-
OVA) that expresses a well-defined model antigen, ovalbumin
(OVA), was used. Specific T cell responses were measured by CTL
killing assays of spleen preparations taken 9 days post infection and
expanded in culture by in vitro boosting with MHC I immunodo-
minant OVA(257–264) peptide. The ability of activated CD8 T cells
to kill target cells presenting OVA(257–264) peptide in the context of
H-2K
b was measured. Splenic CTLs from i.v. infection were
found to have more robust killing capacity compared to those
generated following oral infection (Fig. 1). However, specific
responses could be measured following oral infection thereby
allowing us to assess the contribution of cross-priming in an oral
bacterial infection model, which is the natural route of infection of
this bacterium.
DY mice are deficient in generating Listeria-derived
specific CD8 T cell responses in vivo
To gain insight into the role of cross-presentation for priming T
cell responses following bacterial infection, we evaluated CD8 T
cell responses following Listeria-OVA infection in the H-2K
b
transgenic models. Cross-presentation is uniquely inactivated in
the DY mice thereby allowing the contribution of cross-priming
during oral infection to be tested specifically. Interestingly,
transgenic mice showed increased susceptibility to Listeria-OVA
infection and thus lower infection doses were administered for sub-
lethal infection.
CTL killing assays were performed to test the efficiency of
activated T cells from infected spleens of transgenic mice to
recognize and lyse target cells. Equal numbers of splenic CTLs
from K
bWT and DY were used in the assays and differed
significantly in their ability to kill peptide-pulsed targets at
infection doses of 5e7 cfu (p,0.05) and 1e6 cfu (p,0.005) tested
(Fig. 2A). Quantification of Listeria-specific CD8 T cells was
performed on spleen and draining mesenteric lymph nodes (MLN)
from K
bWT and DY mice following oral gavage infection.
Splenocytes were re-stimulated in vitro with MHC I immunodo-
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detect H-2K
bOVA(257–264) specific CD8 T cells. DY mice had
significantly lower percentage of H-2K
bOVA(257–264) CD8 T cells
in spleen (Fig. 2B) indicating that DY mice are deficient in
developing antigen specific CD8 T cell responses to Listeria
infection. Quantification of Listeria-OVA-specific CD8 T cells was
also performed on MLN directly ex vivo following oral gavage
infection transgenic mice. Again, DY mice generated significantly
fewer H-2K
b OVA(257–264)-specific CD8 T cells following Listeria-
OVA infection (Fig. 2C). The results indicate that antigen-specific
CD8 T cells from DY mice are deficient in developing cytotoxic T
cell responses following infection.
Notably, the percentage of total CD8 T cells generated in spleen
following Listeria infection was observed lower in DYs p l e e n
compared to mock, K
bWT or C57BL/6 infections. Indeed, T cell
depletion following Listeria infection has been reported but only in
the first 48 h of infection [31,32]. To examine whether Listeria
bacterial infection resulted in significant depletion of T cells in
spleen, 9 days post infection, analysis of CD8 T cell numbers
following invitro stimulation wascarried out.The numbers of CD8T
cells were significantly lower in DY mice compared to K
bWT while
the numbers of CD4 T cells did not significantly differ (Fig. 3A, B).
DY DCs are deficient in stimulating CD8 T cell responses
following Listeria infection in vitro
Dendritic cells from K
bWT and DY mice are used to extend the
original findings that the highly conserved tyrosine residue in the
cytoplasmic domain of MHC I is responsible for endolysosomal
trafficking in DCs thereby allowing processing of exogenously-
derived antigen for cross-presentation [5]. To address the function
of H-2K
b molecular trafficking on antigen processing for
presentation and activation of T cell responses, we evaluated T
cell activation and proliferation following Listeria-OVA infection of
DCs from transgenic mice in vitro.
Figure 1. Antigen specific CD8 T cell responses in C57BL/6 mice
differ following Listeria-OVA oral and i.v. routes of infection.
C57BL/6 mice were infected with 1e
9 cfu or 1e
4 cfu Listeria-OVA by oral
gavage or i.v. injection, respectively. Mock oral infections were
performed with 0.1 M HEPES-PBS (Mock) while PBS alone was used
for mock i.v. infections. At the peak of the cellular response, 9 days post
infection, spleens were harvested and the cytolytic capacity of CD8 T
cells was analysed in a standard
51-Cr release assay. T cells were
expanded in culture with OVA(257–264)-specific peptide for 6 days.
Effector T cells were then incubated with OVA(257–264) peptide pulsed,
sodium chromate-labeled target cells and their ability to lyse targets
was measured at indicated ratios. Experiments were performed in
triplicate with 3 mice per group.
doi:10.1371/journal.pone.0007210.g001
Figure 2. DY mice are deficient in generating specific CD8 T cell
responses following Listeria-OVA infection. K
bWT and DYm i c e
were orally infected with 5e
7 or 1e
6 cfu Listeria-OVA or mock infected
with 0.1 M HEPES-PBS. Spleens and MLN were harvested 9 days post
infectionandanalyseddirectlyexvivoor specific Tcellswereexpandedin
culture by incubation with OVA(257–264) peptide A, Cytotoxicity assays
were performed whereby OVA(257–264)peptide pulsed, sodiumchromate-
labeledtarget cellswereincubatedwithrestimulatedeffector Tcellsfrom
spleens of infected mice. The ability of effector T cells to lyse targets was
measured as chromiumrelease atindicatedratios. 2 mice pergroupwere
analysed for each dose of infection tested. Cytotoxicity experiments were
performed in triplicate. B, C, Listeria-derived OVA(257–264)-specific CD8 T
cells from spleens or MLN of 2 mice per group were quantified by
tetramer staining following oral infection with 5e
7 cfu Listeria-OVA and
restimulation of the T cells in vitro (B) or analysed directly ex vivo (C).
Results arepresented as bar graphs of fold increases in % tetramer/CD8 T
cells stained plus SD; Student’s t test *, p,0.05.
doi:10.1371/journal.pone.0007210.g002
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transgenic K
bWT and DY mice by 10 day culture with GM-CSF.
DCs from wild type and mutant transgenic mice both express
equivalent amounts of the DC-specific marker, CD11c, MHC I
and class II molecules on their surface (data not shown).
DCs were infected with Listeria-OVA at MOIs, as indicated.
Infections were terminated after 4 h by washing to remove
extracellular bacteria and resuspending the cells in media with
10 mg/ml chloramphenicol to kill any remaining extracellular
bacteria. DCs were allowed to process and present endogenously-
derived (from direct infection) and any remaining exogenously-
derived (from dead bacteria) bacterial antigens overnight. After
18 h, DCs were incubated with B3Z T cells, a T cell hybridoma
that is activated by the recognition of H-2K
b in association with
OVA(257–264) peptide. K
bWT and DY DCs infected with Listeria-
OVA were equally adept to process Listeria-derived antigens to
activate B3Z T cells in a dose-dependent manner (p,0.005,
p,0.0005) while infected TAP12/2 DCs were unable to activate
B3Z (Fig. 4A). Interestingly, DY DCs showed reduced ability to
Figure 3. Depletion of CD8 T cells in DY spleen following
Listeria-OVA infection. K
bWT and DY mice were orally infected with
5e
7 cfu Listeria-OVA or mock infected with Hepes buffered PBS. Infected
spleens were harvested 9 days post infection and OVA-specific T cells
expanded in culture for 5 days by incubation with specific OVA(257–264)
peptide. Cells were then counted by trypan blue exclusion and CD8 and
CD4 T cells were stained and analysed by flow cytometry. Numbers of T
cells were calculated and are presented as a bar graph plus SD of 2 mice
per group infected; student’s t test *, p,0.05.
doi:10.1371/journal.pone.0007210.g003
Figure 4. DY DCs have decreased ability to activate T cells
following in vitro infection with Listeria-OVA. Bone marrow
preparations from K
bWT and DYm i c ew e r ec u l t u r e din vitro with GM-
CSF to develop bmDCs. After 10 days in culture, cells were labeled with
CD11c and H-2K
b andanalysedbyflowcytometry. A, Day 10bmDCs from
K
bWT,DYorTA P1
2/2micewereinfectedwithincreasingdosesofListeria-
OVA for 4 h. After 4 h infection time, extracellular bacteria were removed
and DCs were subsequently incubated overnight to allow processing of
internalized bacteria. DCs were then incubated with the B3Z T cell
hybridoma for 18 h and T cell activation was measured using a CPRG
chemiluminescent assay. Uninfected bmDCs from of K
bWT, DYo r
TAP1
2/2 mice served as negative controls. B, Data is presented as a
fold increase in T cell activation by dividing CPRG absorbance values by
background C. uninfected bmDCs from K
bWT, DYo rT A P 1
2/2 mice were
incubated with indicated doses of soluble whole OVA. Processing of
internalized OVA was allowed to take place overnight followed by
incubation with B3Z T cell hybridoma for 18 h before measuring T cell
activation.BmDCswerealsopulsedfor1 hwith1 mMOV A (257–264)-specific
peptide as positive control. Experiments were performed in triplicate and
values are presented as means plus SD with Student’s t tests * p,0.05;
** p,0.005; ***p,0.0005.
doi:10.1371/journal.pone.0007210.g004
Antigen Cross-Presentation
PLoS ONE | www.plosone.org 4 October 2009 | Volume 4 | Issue 10 | e7210activate B3Z T cells compared to K
bWT DCs when differences in
background were taken into account (Fig. 4b), although the
statistical significance was smaller (p,0.05) compared to the dose
dependant activation found for both K
bWT and DY DCs,
indicating a smaller contribution of cross-presentation, probably
from extracellular dead bacteria, compared to direct presentation
in vitro. In addition, cross-presentation of soluble whole OVA by
K
bWT but not DY DCs was observed as had been previously
shown (Fig. 4C).
DY APCs are deficient in stimulating naı ¨ve T cell
proliferation following Listeria-OVA infection
Antigen processing and presentation to stimulate naı ¨ve T cells
was next tested. For this, freshly isolated splenocytes were counted
and infected with Listeria-OVA for 4 h before washing and
resuspending cells in media plus antibiotics to terminate the
infection. Eighteen hours later, cells were incubated with naı ¨ve
CD8 OT-I T cells which recognize APCs presenting OVA(257–264)
peptide in the context of H-2K
b molecules.
3H-[Thy] incorpora-
tion by proliferating OT-I in response to activation was measured
48 h later. Similarly to what was found in bmDC infections, both
K
bWT and DY splenocytes processed and presented Listeria-
derived antigen to stimulate naı ¨ve CD8 T cell proliferation in a
dose dependant manner (p,0.005, p,0.0005) (Fig. 5A). Signif-
icant differences between DY and K
bWT splenocytes to activate
OT-I T cells were also observed (p,0.05, p,0.005) (Fig. 5B)
indicating the role of cross-presentation for processing and
presenting Listeria-OVA antigens.
Loading and Presentation of Listeria-OVA-derived
antigens on DY and K
bWT APCs
In vitro infection of DCs and APCs indicated that the deficiency
observed in DY mice to generate CD8 T cell responses against
Listeria-OVA lies in its APCs, which are defective in stimulating
fully functioning T cells. To address the mechanism of the defect,
the antigen processing and loading capacity following Listeria-OVA
infection was investigated in DY and K
bWT splenocytes.
Following 4 h infection with Listeria-OVA, splenocytes were
incubated overnight and surface stained with the mAb 25.D1.16
which specifically recognizes H-2K
b-OVA(257–264) complexes.
Both DY and K
bWT splenocytes showed loading and presentation
of Listeria-OVA derived antigen (Fig. 6A). Marginal differences in
loading and presentation were observed between DY and K
bWT
splenocytes at MOI 0.001 and MOI 0.1 but were not significant
by students’ t test (Fig. 6B). Interestingly, infected DY splenocytes
pulsed with OVA(257–264) peptide resulted in significantly less
presentation of H-2K
b-OVA(257–264) complexes (Fig. 6B). Expres-
sion of H-2K
b molecules is normally similar or higher on DY
APCs compared to K
bWT APCs [6]. The latter result indicates
that aberrant recycling of MHC I molecules on DY APCs which
has been shown previously [6], may contribute to the decreased
overall levels of surface H-2K
b-OVA(257–264) complexes following
infection and peptide pulsing.
Discussion
The physiological relevance of cross-presentation in vivo has
been related to the need to generate CTL immunity to virus-
infected cells and tissue-specific viruses [5,16] or following major
virus and tumor escape mechanisms resulting in down-regulation
of antigen presentation [33,34]. Cross-presentation is now
established under various investigational conditions as a funda-
mental pathway of activating CD8 T cells but understanding its
significance for mounting immune responses in vivo has been
limited by experimental means to distinguish cross-priming from
overall MHC I priming. Here, we have taken advantage of a
transgenic mouse model in which a tyrosine motif in the
cytoplasmic tail of MHC I has been mutated. This mutation
abrogates the targeting of MHC I molecules to endolysosomal
compartments where they may undergo peptide exchange and
acquire exogenously derived antigens for cross-presentation [5,6].
In this context, we have used the mouse model to examine the role
of cross-presentation of bacterially-derived antigens following
Listeria infection in vivo.
During naturally acquired infection, bacteria traverse the
epithelial-cell layer and disseminate in the bloodstream to other
organs, such as the spleen and liver, [30]. We show that the ability
to generate Listeria-specific CD8 T cells with cytotoxic capacity is
affected by the route of infection. Systemic infection induced by
i.v. injection of Listeria-OVA produced specific CD8 T cells with
Figure 5. DY APCs have decreased ability to stimulate naive T
cell proliferation following in vitro infection with Listeria-OVA.
A. Splenocytes from K
bWT and DY mice were infected with increasing
doses of Listeria-OVA. Following 4 h infection, extracellular bacteria
were removed and infected cells were incubated overnight. APCs were
then cultured with OT-I T cells for 48 h. [
3H]-Thymidine was then added
to the cultures and 24 h later, proliferation was measured by [
3H]-Thy
incorporation. B. Data is presented as fold increases in T cell
proliferation. Values are calculated by dividing [3H]-Thy count values
by background. Experiments were performed in triplicate and values
are presented as means plus SD with Student’s t tests * p,0.05;
** p,0.005; ***p,0.0005.
doi:10.1371/journal.pone.0007210.g005
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still able to detect significant OVA-specific T cells with killing
capacity following oral gavage infection, mimicking the natural
route of infection of the bacterium. Interestingly, transgenic mice
showed increased susceptibility to infection compared to wild type
C57BL/6 regardless of the route of administration and therefore
required a 20-1000 fold reduction in the dose of bacteria used for
infection. This may be due in part to the different background
strain of the transgenic mice since the expression of the H-2K
b and
DY H-2K
b mutant genes have been bred to C3H/He animals and
particular strains of mice have been shown to have distinct
differences in resistance or susceptibility to Listeria [35].
The novel findings that antigen-specific T cells are deficient in
number and in function in DY mice following Listeria infection in
vivo demonstrates that development of functional Ag-specific T
cells is severely impaired following infection due to the MHC I
cytoplasmic tail mutation and implies a dependence on MHC I
targeting and cross-presentation of bacterial antigens for loading
and subsequent priming of CD8 T cells. The failure of the CD8
Ag-specific T cells from DY mice to expand following infection
could also be detected as a significantly lower total number of CD8
T cells recovered after infection. A model of early events in the T
cell response to Listeria infection has been described whereby
almost all peripheral T cells become partially activated within one
day. This is followed by massive T cell depletion of nonspecific T
cells while Ag-specific T cells begin to divide and become fully
activated to become the majority of the peripheral T cells by days
7–9, at the peak of the response [31,32]. In this context, we
propose that the cross-presentation deficiency in DY mice results
in T cells receiving inadequate activation signals which do not
clonally expand and instead undergo apoptosis with the manifes-
tation of a large reduction in CD8 T cell number at the peak of
Listeria infection response. Further, DY DCs can only present
endogenously. Therefore, if they become directly infected with
Listeria then they would become targets for any CTL produced,
contributing to the loss in CD8 T cell number.
Cross-presentation of many types of antigens has been reported
[14]. In this work, we have used the MHC I cytoplasmic tail
transgenic mice to dissect the importance of the mechanism of
cross-presentation within the overall context of MHC I presenta-
tion following bacterial infection. We observed that dose-
dependent T cell responses are activated following infection of
K
bWT and DY bmDCs, indicating that the endogenous route of
processing is predominant following direct infection. Following
cellular invasion, Listeria initially occupies an endosome/phago-
some [36,37] but upon acidification of the phagosome, LLO, a
cholesterol-dependent pore-forming toxin, is secreted and blocks
phagosome-lysosome fusion by generating small pores that
uncouple pH and calcium gradients across the phagosome
membrane [38]. This acts to destroy the phagosomal membrane
and allows escape of bacteria into the cytosol where they can
replicate. In this way, Listeria-derived proteins are expected to
deliver predominantly to the endogenous route of processing.
However, we also observed that DCs from DY mice showed
significantly reduced ability to activate T cells following direct
infection with Listeria-OVA in vitro indicating the contribution of
cross-presentation, probably due to the presence of extracellular
dead bacteria. In addition, DCs have been shown to have a special
ability to alkalinize phagosomes through the activity of NADPH
oxidase [39]. LLO-mediated escape of Listeria to the cytosol can be
inhibited by alkalinization of the phagosome [37] and bacterial
escape from vesicles is approximately 10-fold less active at neutral
compared to acidic pH [40]. Thus, the pH of DC Listeria-
containing phagosomes may influence the timing of bacterial
escape and also contribute to the exogenous route of processing
following direct infection with Listeria.
Our previous studies demonstrated that MHC I tyrosine-based
motif is required for constitutive internalization of MHC I
Figure 6. Exchange of H-2K
bOVA peptide is affected by MHC I
tyrosine mutation on DY APCs. Splenocytes from K
bWT and DY
mice were infected with Listeria-OVA between 0.001–0.1 MOI. Follow-
ing 4 h infection, extracellular bacteria were removed and infected cells
were incubated overnight. A. APCs were surface stained with a
monoclonal antibody (mAb 25.D1.16) that specifically recognizes H-2K
b-
OVA(257–264) complexes and analysed by flow cytometry. Uninfected
APCs or infected APCs pulsed with 1 mM OVA(257–264) peptide for 1 h
were used as negative and positive controls, respectively. B. Data is
represented as a bar graph of the mean fluorescence intensity (MFI) of
surface H-2K
bOVA(257–264) complexes. Experiments were performed in
triplicate and values are presented as average MFI plus SD with
Student’s t tests * p,0.05.
doi:10.1371/journal.pone.0007210.g006
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lysosomes where loading of exogenously-derived antigen can
occur [6]. It is proposed that surface K
bWT molecules form an
abundant source of MHC I for endosomal and lysosomal peptide-
loading of exogenously-derived bacterial antigens. We examined
loading of Listeria-OVA-derived antigens on APCs following direct
infection of APCs and staining of MHC I-OVA complexes and
despite significant differences between DY and K
bWT APCs to
stimulate T cell responses, were unable to detect significant
differences in processing and loading of Listeria-derived OVA
antigen. However, significant differences in the level of surface H-
2K
b-OVA(257–264) complexes could be detected following infection
and peptide pulsing. Considering our previous results, we propose
that following infection, MHC molecules internalizing from the
surface do not sort to compartments compatible with cross-
presentation for recycling to the surface, causing an overall
decrease in the level of H-2K
b-OVA(257–264) complexes present.
The equilibrium of surface levels of MHC I molecules is a balance
between new synthesis and constitutive internalization for
degradation or recycling. Therefore, we conclude that aberrant
recycling of MHC I molecules on DY APCs following infection
may contribute to the decreased overall levels of surface H-2K
b-
OVA(257–264) complexes, the differences of which are only
detectable following peptide pulsing.
Overall, the contribution of cross-presentation is likely to differ
depending on mode of infection i.e. direct infection of APCs versus
oral infection in vivo. Figure 7 describes mechanisms of cross-
presentation that may occur depending on the route of infection.
Protease-mediated degradation of the bacterium following direct
infection in vitro within endolysosomal compartments competent
for cross-presentation would provide peptides capable of binding
recycling MHC I molecules. However, our data suggest that
escape of the bacterium into the cytosol is predominant following
infection in vitro whereby the bacterium is subsequently targeted for
proteosome –mediated degradation and endogenous processing.
Conversely, our results establish that, indeed cross-priming of CD8
T cells is an essential mechanism required to generate primary
cellular immune responses following in vivo infection with Listeria.A
mechanism for priming of CD8 T cells following bacterial oral
infection across the gastrointestinal barrier is likely through
bystander acquisition of bacterial antigen. We, and others have
shown that Listeria infection causes substantial depletion of T cells
by apoptosis. These cells may also be infected [41] necessitating
bystander DCs to cross-present and prime CTL. Hereby, we
propose that directly infected cells may undergo apoptosis in vivo,
thereby providing antigenic material for uptake and processing in
cross presenting endolysosomal compartments by bystander DCs.
Indeed, cross-priming initiated by pathogen-induced apoptosis has
Figure 7. Proposed mechanisms of Listeria-derived antigen sampling following in vitro or in vivo infection. Schematic representation of
the mechanisms involved in functional sampling of Listeria-derived antigens depending on the route of infection. A. Listeria directs its own
phagocytic uptake into the cell. Within the phagosome, protease-mediated degradation of the bacterium generates peptides capable of binding
MHC I molecules recycling from the surface, a process dependant on an intact tyrosine (Y) residue in the cytoplasmic tail of the MHC I molecule.
Peptide exchange occurs allowing bacterially-derived antigens to be loaded on MHC I molecules and trafficked to the surface for cross-presentation.
Predominantly, toxin-induced pore-forming of the phagosome occurs to allow the escape of the bacterium into the cytosol. Within the cytosol,
Listeria is targeted for proteosome –mediated degradation and antigen transport to the ER where bacterial peptides are loaded on newly synthesized
MHC I molecules. Loaded MHC I molecules follow the secretory pathway through the trans golgi network (TGN) to the surface for presentation. B.
Following infection in vivo, directly infected cells undergo apoptosis, providing antigenic material for uptake by bystander DCs. In this scenario,
apoptotic material containing bacterially-derived antigens is phagocytosed into a compartment competent for cross-presentation, named the
endolysosomal compartment (ELC). MHC I molecules recycle from the surface into this compartment, peptide exchange occurs and bacterially-
derived peptide antigens are loaded and recycled to the cell surface for cross-presentation.
doi:10.1371/journal.pone.0007210.g007
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20,42] suggesting that transfer of antigens from apoptotic vesicles
to bystander APCs is a general mechanism of cross-priming of
CD8 T cells in infectious disease.The rules of engagement for
initiating and priming immune responses are now being written.
These new edicts will eventually find their application in
modulating autoimmune processes and together with novel
molecular adjuvants, will promote the efficacy of emerging
vaccines. The depth and breath of applying this knowledge is
only beginning to be tapped.
Materials and Methods
Mouse strains and bacterial infections in vivo
C3H/He mice transgenic for the expression of wild-type MHC
I allele H-2K
b (K
bWT) or cytoplasmic tail tyrosine mutant (DY)
were used in these studies as described previously [5]. C57BL/6
mice of H-2K
b haplotype were purchased from Charles River (St.
Constant, QE, Canada). The transporter associated with antigen
processing 1 knock out (TAP12/2) and transgenic OT-I mice
expressing a TCR specific for OVA(257–264) peptide on a C57BL/6
background were purchased from Jackson Laboratory (Br Harbor,
ME). Mice were maintained under specific pathogen-free
conditions and fed the normal mouse diet ad libitum. All mouse
protocols were approved and performed in accordance with the
requirements set out by the Canadian Council on Animal Care.
A recombinant form of Listeria monocytogenes encoding Ovalbu-
min and an erythromycin-resistance marker was used for these
studies (Listeria-OVA). An Antigen expression cassette consisting of
the coding sequence of OVA fused to the signal sequence and
promoter of the hly gene and an erythromycin resistance gene was
introduced into Listeria, and double-crossed onto the Listeria
chromosome by homologous recombination, as previously de-
scribed [43].
Mice were infected with Listeria-OVA by oral gavage with 5e
6-
1e
9 colony forming units (cfu) in 100 ml 0.1 M Hepes-PBS, as
indicated or by i.v. with 1610
4 cfu in 100 ml PBS. Actual cfu were
calculated following infection by plating dilutions of the inoculum.
Mock oral infections were performed with 0.1 M Hepes-PBS. PBS
alone was used for mock i.v. infections.
Detection of CD8-specific T cell responses to Listeria-OVA
At the indicated times following infection, lymphocytes were
isolated by Ficoll-paque (Amersham Biosciences) centrifugation
and OVA-specific CD8 T cells were detected directly using a H-
2K
b/OVA(257–264) tetramer (immunomics-BeckmanCouler
TM).
Otherwise, splenocytes were cultured for 5 days in RPMI 1640
medium (Sigma-Aldrich) supplemented with 10% FCS (HiClone),
100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen Life
Technologies), nonessential amino acids (0.1 mM), sodium
pyruvate (1 mM), 2-mercaptoethanol (50 muM), L-glutamine
(2 mM) and 1 mM OVA(257–264) (SIINFEKL) H-2K
b-restricted
peptide. Following in vitro boosting, CD8 T cells were tetramer
stained and analysed by flow cytometry.
Cytotoxic T lymphocyte (CTL) assays were performed using a
standard
51Chromimum (
51Cr)-release assay. Splenocytes, follow-
ing in vitro boosting with SIINFEKL peptide at 1 mM concentra-
tion for 5 days, were washed and used as effector cells. RMA-S
incubated with 1 mM OVA(257–264) and labeled with sodium
chromate (100 mCi, Amersham) for 1 h were used as target cells.
The CTL activity of activated CD8 T cells was assessed at various
effector: target (E:T) ratios in a 4 h
51Cr-release assay at 37uC.
Percent specific lysis was calculated as 100% x (cpm [experimen-
tal] - cpm [spontaneous release])/(cpm [maximum release] - cpm
[spontaneous release]). All assays were performed in triplicate.
Bone marrow-derived DC culture
Bone marrow-derived DCs (bmDCs) were prepared according
to the procedure developed by Lutz et al. [44]. Cells flushed from
femurs and tibias were plated in RPMI medium (Sigma-Aldrich)
with 10% FBS (HiClone), 100 U/ml penicillin, 100 mg/ml
streptomycin (Invitrogen Life Technologies), nonessential amino
acids (0.1 mM), sodium pyruvate (1 mM), 2-mercaptoethanol
(50 muM), L-glutamine (2 mM) and 1% GM-CSF containing
supernatant from the X-63Ag8-GM-CSF-transfected cell line [45].
Cells were washed on days 3 and 6, 8, with culture media and
0.5% GM-CSF. DCs were routinely 95% CD11c
+ and displayed
low to intermediate levels of CD40, CD80, CD86 and MHC II,
while expressing intermediate levels of MHC I, characteristic of
immature DCs.
Bacterial infection in vitro
bmDCs or splenocytes were harvested and plated in 48-well
plates at a density of 5e
5/well and infected with Listeria-OVA at
0.001-1 multiplicities of infection (MOI) for 4 h in antibiotic-free
medium. After 4 h cells were washed twice in HBSS, resuspended
in media with antibiotics (chloramphenicol, 10 mg/ml; Sigma),
and infected cells were cultured for an additional 18 h. As positive
controls for cross-presentation, bmDCs were incubated with
soluble OVA at 10 and 30 mg/ml concentrations overnight.
BmDCs were also incubated with 1 mM H-2K
b-restricted
OVA(257–264) peptide for 1 h as positive control for B3Z assay.
B3Z T cell activation assay
B3Z is a T cell hybridoma expressing a TCR that specifically
recognizes OVA(257–264) (SIINFEKL) in the context of H-2K
b.
The cells carry a beta-galactosidase (lacZ) construct driven by
nuclear factor of activated T cells elements from the interleukin 2
promoter [46]. Processing and subsequent presentation of Listeria-
derived OVA or soluble OVA was measured using Chlorophenol
Red Galactopyranoside (CPRG, Calbiochem) as a chemilumines-
cent substrate for the detection of lacZ activity in B3Z lysates.
BmDCs were incubated with B3Z cells at 1:1 ratio for 18 h.
Individual cultures were lysed by addition of CPRG lysis buffer
(100 mM 2-ME, 9 mM MgCl2, 0.125% Nonidet P-40, 0.15 mM
chlorophenol red b-galactoside in PBS). Following 18 h incubation
at room temperature, in the dark, absorption was read at 570 nm,
with 650 nm as the reference wavelength. Uninfected bmDCs
incubated with B3Z served as background controls. Fold induction
index was calculated by dividing induced activity by background.
OT-I T cell proliferation assay
Splenocytes were isolated from K
bWT and DY transgenic mice
and were infected with varying MOIs of Listeria-OVA for 4 h
before the infection was terminated by washing cells with HBSS
and resuspending cells in media with 10 mg/ml of chloramphen-
icol. Infected splenocytes were incubated overnight to allow
processing and presentation of Listeria-derived antigens. Next day,
splenocytes were cocultured at a 1:1 ratio with OT-I T cells
expressing a transgenic TCR that specifically recognizes H-2K
b in
complex with OVA(257–264) [47]. T cell proliferation was
determined 48 h later by
3H-thymidine incorporation. Uninfected
splenocytes incubated with OT-I T cells served as background
controls and fold increase in proliferation was calculated by
dividing induced activity by background.
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bOVA(257–264) loaded complexes
Processing and loading of Listeria-OVA-derived antigens on
MHC I was detected with a monoclonal antibody (mAb 25.D1.16)
that specifically recognizes H-2K
b-OVA(257–264) complexes [48].
APCs were blocked anti-mouse Fc receptor (BD) and stained
with biotin labeled antibody mAb 25.D1.16 followed by
phycoerythrin-conjugated rat anti-mouse IgG1 (BD). Cells were
then washed and analysed by flow cytometry. Uninfected APCs or
infected APCs pulsed with 1 mM OVA(257–264) peptide for 1 h
were used as negative and positive controls, respectively.
Statistical Analysis
A student’s T test was used to compare numbers and
percentages of CD4/CD8 or H-2K
bOVA(257–264) tetramer labeled
cells from K
bWT and DY transgenic mice. Statistical differences in
B3Z T cell activation between K
bWT, DY and TAP12/2 mice
were also analyzed by student’s T tests. Differences between two
populations were considered statistically different if *p,0.05,
**p,0.005 or ***p,0.0005.
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